Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sarah Gheuens currently holds 64,795 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Gheuens has been a net seller of AGIO stock. They have purchased $0 and sold $1.2M worth of shares.
Sarah Gheuens's most recent insider trade was on Dec 30, 2025, when they sold 6,000 shares at $0.00 per share.
Sarah Gheuens serves as Executive at AGIOS PHARMACEUTICALS, INC. (AGIO). They have executed 49 insider transactions totaling $1.2M over their tenure at the company.
Sarah Gheuens holds the position of Executive at AGIOS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sarah Gheuens has shown a selling trading pattern, with $0 in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sarah Gheuens was on Jul 9, 2025, when they sold $419.8K worth of AGIO shares. This transaction involved 11,067 shares at $37.93 per share.
Sarah Gheuens currently owns 64,795 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sarah Gheuens's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sarah Gheuens has 49 Form 4 filings on record as an insider at AGIOS PHARMACEUTICALS, INC..
Set alerts for Sarah Gheuens and 40,000+ other insiders.